February 28/Amsterdam/ADP News Netherlands -- DSM has finalized the previously announced acquisition of U.S. Martek Biosciences, a specialist in baby food ingredients, for some 790 million euros ($1.1 billion).
DSM, which announced the deal in December 2010, expects that it will immediately boost its annual earnings per share by 0.15-0.20 euros.